For decades, parents, teachers, and lawmakers have warned that marijuana is a gateway drug, meaning that people who start with cannabis are likely to move on to cocaine, heroin, and other illicit drugs. This is the third article in our series on why marijuana is still illegal, after our look at federal and state cannabis laws and our guide to cannabis addiction. Below, we look at what large surveys, twin studies, and animal research show, and where the evidence is still unclear.
Short answer: Marijuana use usually comes before other illicit drug use, and people who use cannabis are more likely to use other drugs later. But most cannabis users do not go on to use harder drugs, and researchers have not found conclusive evidence that cannabis causes later drug use, rather than shared risk factors such as genetics, mental health, and social environment.
What Is the Gateway Drug Theory?
The gateway theory says that using one substance raises the chance of later using more dangerous drugs. Columbia University researcher Denise Kandel described this sequence in the 1970s, finding that beer, wine, and cigarettes typically precede marijuana among young people, and marijuana typically comes before other illicit drugs.
Over time, the idea became a political argument. Lawmakers and anti-drug campaigns used the gateway drug label to explain why cannabis should stay illegal while alcohol and tobacco stay legal. The message stuck because many people who used heroin or cocaine had tried marijuana first, which made the sequence look like cause and effect.
The question researchers ask is narrower. Does marijuana use itself change the brain or behavior in a way that leads to harder illicit drug use, or do the same people who are drawn to cannabis also tend to try other substances?
What the Research Shows About Cannabis Use and Other Illicit Drugs
A large U.S. study analyzed survey histories from 6,624 adults in the National Epidemiologic Survey on Alcohol and Related Conditions who had used cannabis before any other illegal drug. The researchers estimated a 44.7% lifetime probability that they would later use another illicit drug (Secades-Villa et al., 2015).
That same study found the risk depended heavily on personal factors, including age, sex, psychiatric comorbidity (having a mental illness), and a family history of substance use. Put another way, most users in the sample were not expected to have any subsequent use of other illicit drugs.
Twin studies try to separate cannabis from family background. In a 2003 JAMA study of 311 Australian twin pairs in which one twin used cannabis before age 17 and the other did not, the early user had 2.1 to 5.2 times the odds of using other drugs or developing drug and alcohol dependence. The authors noted that this association does not by itself prove a causal link.
The National Institute on Drug Abuse (NIDA) reports that marijuana use typically precedes the use of other illicit drugs and is linked to a higher risk of alcohol use disorder and nicotine addiction. NIDA also states that most people who use marijuana do not go on to harder drug use.
The National Academies of Sciences, Engineering, and Medicine reviewed the research in its 2017 report on cannabis health effects. It found moderate evidence of a statistical association between cannabis use and developing dependence on alcohol, tobacco, and other illicit drugs, which shows the two are related but not that they are causally linked.
Is Cannabis the Cause? Correlation vs. Common Risk Factors
Many addiction researchers favor a common liability model. It holds that genetics, mental health, stress, and environment shape a person's addiction vulnerability for many substances at once, and that the order in which someone tries drugs is "variable and opportunistic," according to a 2012 review in Drug and Alcohol Dependence.
Cross-national data support that view. A World Health Organization survey of 17 countries found that the order of first drug use changed with how common each substance was in that country, and in Japan, where cannabis is uncommon, use of other illicit drugs was more common than cannabis use.
Social setting also matters. NIDA notes that people who are more vulnerable to drug use may start with whatever is easily accessible, often alcohol, tobacco, or marijuana. Their social contacts with other drug users may then raise their chances of trying other drugs.
In 2018, the National Institute of Justice published a literature review, Is Cannabis a Gateway Drug?, which examined 23 studies of illicit drug use and found mixed results. Many studies showed a statistically significant link, but none offered conclusive evidence that cannabis causes harder illicit drug use. Its key findings concluded that "no causal link between cannabis use and the use of other illicit drugs can be claimed at this time."
Animal Research, Brain Priming, and Adolescent Cannabis Use
The strongest case for a biological gateway comes from animal studies. NIDA describes research on adolescent cannabis exposure in which young rats given THC later showed weaker responses in the brain's dopamine reward system, and THC primed the rats to respond more strongly to morphine, an effect called cross-sensitization.
Animal results do not prove the same thing happens in people, and NIDA notes that alcohol and nicotine produce similar priming effects. Researchers also cannot ethically give THC to teenagers in controlled trials, so human evidence comes from surveys and twin studies, which can show patterns but cannot prove cause and effect. In fact, the clearest molecular evidence involves nicotine, not cannabis.
In a 2014 New England Journal of Medicine paper titled "A Molecular Basis for Nicotine as a Gateway Drug," Eric and Denise Kandel of Columbia University reported that mice given nicotine for seven days responded more strongly to cocaine, with changes in gene activity in the striatum and in signaling in the nucleus accumbens, both part of the brain's reward circuit. In human survey data, 87.9% of cocaine users aged 18 to 34 had started smoking cigarettes before using cocaine, according to Psychiatric News, and the authors warned that e-cigarettes could act as a gateway for the same reason.
Starting young raises the risk. The CDC notes that the brain keeps developing until about age 25, and that people who start using during adolescence face an increased risk of cannabis use disorder. The same page says teens who use cannabis are more likely to have lasting effects on brain development.
Prescription Opioid Misuse and Heroin Use
Research on heroin also points to prescription opioids. Using national survey data from 2002 to 2012, NIDA reports that heroin initiation was 19 times higher among people who had misused prescription pain relievers than among people who had not. NIDA also reports that nearly 80% of people who use heroin used prescription opioids first, although these figures do not compare prescription opioids with marijuana.
A 2014 study in JAMA Psychiatry surveyed 2,797 people entering treatment for heroin use and found that 75% of more recent users said their first opioid was a prescription drug. That pattern reflects the opioid addiction crisis that grew alongside widespread painkiller prescribing.
Legalization research has not settled the cannabis question either. A study of national survey data from 2004 to 2020 found mixed links between recreational cannabis laws and the use of opioids, stimulants, and alcohol, and its authors said the design could not prove cause and effect.
What the Gateway Debate Means for Cannabis Laws and Consumers
The gateway drug argument helped justify strict marijuana laws for decades, and our article on the laws that regulate cannabis continues this series. The evidence today supports a narrower conclusion: early and heavy cannabis use is a warning sign worth taking seriously, but the research does not show that marijuana causes later heroin or cocaine use.
For young people, the CDC says that starting cannabis use in adolescence raises the risk of cannabis use disorder, and the Kandel research raises the same concern about underage smoking and e-cigarettes. Anyone worried about drug abuse or other substance use disorders, including opioid use disorder, can call the Substance Abuse and Mental Health Services Administration (SAMHSA) National Helpline at 1-800-662-4357, which offers free, confidential treatment referrals 24 hours a day.
True Blue terpenes are botanically derived and contain no THC or CBD, so they will not get you high. Our strain profiles recreate the aroma and taste of popular cannabis strains, and our guides explain how non-intoxicating terpenes work, why cannabis businesses use botanical terpenes, and how to use weed flavor drops.